Why is Morepen Labs. falling/rising?

As of 19-Nov, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 45.52, reflecting a decrease of 0.22 or 0.48%. The stock has underperformed its sector by 0.55% today and has been on a consecutive downward trend for the last five days, resulting in a total decline of 3.44% over that period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has generated a return of -40.00%, while its profits have fallen by 42.6%. The company has also reported negative results for the last three consecutive quarters, contributing to a lack of investor confidence, as indicated by the low participation from domestic mutual funds.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has gained 0.85% over the past week and 1.47% over the past month. While the Sensex has shown positive returns year-to-date at 9.02%, Morepen Laboratories has significantly lagged behind with a year-to-date decline of 41.86%. This underperformance, coupled with poor long-term growth indicators such as low net sales growth and declining operating profit, suggests that investor sentiment remains negative towards the stock, further exacerbated by its low debt-to-equity ratio and fair valuation compared to peers.